Centrient has agreed to acquire Indian contract development and manufacturing organization Astral SteriTech, giving the antibiotics, statins and anti-fungals producer access to expanded capabilities including sterile injectable antibiotic finished-dose products.
Centrient Acquires India’s Astral SteriTech
Expands Capabilities Into Sterile Injectable Antibiotics
Antibiotics specialist Centrient has struck a deal to acquire India’s Astral SteriTech in a move that will expand its portfolio to include sterile injectable finished-dose products.
